Use of Hand Prosthesis With Surface Electrical Stimulation for Treatment of Phantom Limb Pain
EPIONE
Natural Sensory Feedback for Phantom Limb Modulation and Therapy
2 other identifiers
interventional
2
1 country
1
Brief Summary
Phantom limb pain (PLP) is a frequent consequence of amputation, and it is notoriously difficult to treat. Amputation usually follows traumatic injuries or surgery following vascular diseases, diabetes, osteomyelitis or tumours in cases where the loss of the limb is required for the survival of the patient. The loss of a limb or other body parts is usually followed by the sensation that the lost body part is still present and can be felt. These phenomena are called, respectively, phantom awareness and phantom sensation. In 50-80% of amputees neuropathic pain develops in the lost limb also referred to as phantom limb pain (PLP). PLP can be related to a certain position or movement of the phantom limb, and might be elicited or worsened by a range of physical factors (e.g. changes in the weather or pressure on the residual limb) and psychological factors (e.g. emotional stress). It is well known that most treatments available for PLP today, such as pharmacological, surgical, anaesthetic, psychological and other, are ineffective. Today it is believed that phantom limb pain may be related to changes in the cortex of the brain. There is evidence that these changes may be modulated - or even reversed - by providing sensory input to the stump or amputation zone. For example, cortical reorganization and alleviation of phantom limb pain has been observed in amputees following intense use of a hand prosthesis. However, there is no consistent knowledge on which type of peripheral sensory feedback may be effective in affecting the cortical plasticity or on how to best apply the sensory feedback. The aim of the proposed research is to create natural, meaningful sensations through providing non-invasive sensory feedback (i.e. surface electrical stimulation) and the effectiveness to alleviate phantom limb pain and restore the cortical neuroplastic changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 6, 2015
CompletedFirst Posted
Study publicly available on registry
October 7, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedNovember 14, 2017
November 1, 2017
2.8 years
October 6, 2015
November 10, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Phantom limb pain
The pain intensity will be assessed using visual analog scale (VAS)
Change in phantom limb pain perception between baseline measurements and 3 months
Cortical reorganization
The cortical response to peripheral stimulation will be tracked using MRI
Change in cortical reorganization between baseline measurements and 3 months
Secondary Outcomes (2)
Phantom limb pain
Change in neuropathic pain symptoms between baseline measurements and 3 months
Cortical reorganization
Change in in cortical reorganization between baseline measurements and 3 months
Study Arms (1)
Surface electrical stimulation
EXPERIMENTALOperation of hand prosthesis with surface electrical sensory feedback
Interventions
Surface electrical stimulation using the following experimental devices. 1) The CE-approved HASOMED electrical isolated stimulator (Rehastim). 2) Two hand prosthesis: the robotic hand "Azzurra" (Prensilia, Italy) and the robotic hand "Multi-sensory Prosthetic Hand" (Wessling robotics, Germany) 3) The EPIONE Psychophysical Testing Platform software for stimulator control. Surface stimulation therapy is provided while providing visual guidance to the subject.
Eligibility Criteria
You may qualify if:
- Amputation or peripheral nerve damage of an upper limb.
- Injury should be in the chronic, stable phase, such that any traumatic injuries or surgical wounds have healed and the person apart from eventual phantom pain (PLP) is healthy and able to carry out experiment.
- Other treatments for PLP tried with poor results.
- Patient accepts the study protocol as explained by the physician.
- The subject experienced intractable PLP (i.e. pain in the denervated or missing extremity) of more than 6 on numerical rating scale (NRS) or visual analog scale (VAS) (0-10 scale). The frequency of PLP episodes presents more than once a week.
- Amputee subjects without PLP are eligible for part of the study that targets the sensory feedback induction within advanced bidirectional prosthesis control.
You may not qualify if:
- Cognitive impairment
- Current or prior psychological impairments: Major personality disturbance (i.e. borderline, antisocial), Major depression, Bipolar I.
- Pregnancy
- History of or active substance abuse disorder
- Acquired brain injury with residual impairment
- Intellectual Disability (IQ \< 70)
- Prior neurological or musculoskeletal disease
- Current or prior dermatological conditions
- Excessive sensitivity to electrical stimulation with surface electrodes. People afraid of electrical stimulation or pain.
- People with other diseases which may affect the function of the nervous system. (Diabetes, HIV, Renal Failure)
- Patients implanted with pacemakers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Prof. Wassim Raffoullead
- Aalborg University Hospitalcollaborator
- University of Freiburgcollaborator
- Université Montpelliercollaborator
- Lund Universitycollaborator
- Indiana University School of Medicinecollaborator
- Novosense ABcollaborator
- Mxm-Obeliacollaborator
- Ecole Polytechnique Fédérale de Lausannecollaborator
- Universitat Autonoma de Barcelonacollaborator
- Catholic University of the Sacred Heartcollaborator
- Aalborg Universitycollaborator
Study Sites (1)
University of Lausanne Hospital CHUV
Lausanne, Canton of Vaud, 1011, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wassim Raffoul, Professor
University of Lausanne Hospitals
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 6, 2015
First Posted
October 7, 2015
Study Start
February 1, 2015
Primary Completion
November 1, 2017
Study Completion
November 1, 2017
Last Updated
November 14, 2017
Record last verified: 2017-11